FDA Inspection 1108743 — Philip Halverson, M.D.
The FDA completed an inspection of Philip Halverson, M.D. on October 22, 2019 in Plymouth, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 22, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plymouth, MN (United States)
Additional Details
Clinical Investigator (CI)